Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'".

Authors

Korakas, Emmanouil; Kountouri, Aikaterini; Pavlidis, George; Oikonomou, Evangelos; Vrentzos, Emmanouil; Michalopoulou, Eleni; Tsigkou, Vasiliki; Katogiannis, Konstantinos; Pliouta, Loukia; Balampanis, Konstantinos; Pililis, Sotirios; Malandris, Konstantinos; Tsapas, Apostolos; Siasos, Gerasimos; Ikonomidis, Ignatios; Lambadiari, Vaia